Literature DB >> 19014780

Overview of radiosensitivity of human tumor cells to low-dose-rate irradiation.

Jerry R Williams1, Yonggang Zhang, Haoming Zhou, Daila S Gridley, Cameron J Koch, James M Slater, John B Little.   

Abstract

PURPOSE: We compared clonogenic survival in 27 human tumor cell lines that vary in genotype after low-dose-rate (LDR) or high-dose rate (HDR) irradiation. We measured susceptibility to LDR-induced redistribution in the cell cycle in eight of these cell lines. METHODS AND MATERIALS: We measured clonogenic survival after up to 96 hours of LDR (0.25 Gy/h) irradiation. We compared these with clonogenic survival after HDR irradiation (50 Gy/h). Using flow cytometry, we measured LDR-induced redistribution as a function of time during LDR irradiation in eight of these cell lines.
RESULTS: Coefficients that describe clonogenic survival after both LDR and HDR irradiation segregate into four radiosensitivity groups that associate with cell genotype: mutant (mut)ATM, wild-type TP53, mutTP53, and an unidentified gene in radioresistant glioma cells. The LDR and HDR radiosensitivity correlates at lower doses ( approximately 2 Gy HDR, approximately 6 Gy LDR), but not at higher doses (HDR > 4 Gy; LDR > 6 Gy). The rate of LDR-induced loss of clonogenic survival changes at approximately 24 hours; wild-type TP53 cells become more resistant and mutTP53 cells become more sensitive. Redistribution induced by LDR irradiation also changes at approximately 24 hours.
CONCLUSIONS: Radiosensitivity of human tumor cells to both LDR and HDR irradiation is genotype dependent. Analysis of coefficients that describe cellular radiosensitivity segregates 27 cell lines into four statistically distinct groups, each associating with specific genotypes. Changes in cellular radiosensitivity and redistribution in the cell cycle are strongly time dependent. Our data establish a genotype-dependent time-dependent model that predicts clonogenic survival, explains the inverse dose-rate effect, and suggests possible clinical applications.

Entities:  

Mesh:

Year:  2008        PMID: 19014780     DOI: 10.1016/j.ijrobp.2008.06.1928

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Extracting the normal lung dose-response curve from clinical DVH data: a possible role for low dose hyper-radiosensitivity, increased radioresistance.

Authors:  J J Gordon; K Snyder; H Zhong; K Barton; Z Sun; I J Chetty; M Matuszak; R K Ten Haken
Journal:  Phys Med Biol       Date:  2015-08-21       Impact factor: 3.609

2.  Generation and characterization of a cell line from an intraductal tubulopapillary neoplasm of the pancreas.

Authors:  Matthäus Felsenstein; Maria A Trujillo; Bo Huang; Neha Nanda; Zhengdong Jiang; Yea Ji Jeong; Michael Pflüger; Michael G Goggins; Ralph H Hruban; Elizabeth D Thompson; Christopher M Heaphy; Nicholas J Roberts; Laura D Wood
Journal:  Lab Invest       Date:  2020-01-31       Impact factor: 5.662

3.  Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management.

Authors:  Vicente Valero; Tyler J Saunders; Jin He; Matthew J Weiss; John L Cameron; Avani Dholakia; Aaron T Wild; Eun Ji Shin; Mouen A Khashab; Anne Marie O'Broin-Lennon; Syed Z Ali; Daniel Laheru; Ralph H Hruban; Christine A Iacobuzio-Donahue; Joseph M Herman; Christopher L Wolfgang
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 4.  Tissue and data archives from irradiation experiments conducted at Argonne National Laboratory over a period of four decades.

Authors:  Qiong Wang; Tatjana Paunesku; Gayle Woloschak
Journal:  Radiat Environ Biophys       Date:  2010-03-23       Impact factor: 1.925

5.  89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man.

Authors:  Bastiaan M Privé; Yvonne H W Derks; Florian Rosar; Gerben M Franssen; Steffie M B Peters; Fadi Khreish; Mark Bartholomä; Stephan Maus; Martin Gotthardt; Peter Laverman; Mark W Konijnenberg; Samer Ezziddin; James Nagarajah; Sandra Heskamp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-12-21       Impact factor: 10.057

6.  NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance.

Authors:  Francesco Marampon; Silvia Codenotti; Francesca Megiorni; Andrea Del Fattore; Simona Camero; Giovanni Luca Gravina; Claudio Festuccia; Daniela Musio; Francesca De Felice; Valerio Nardone; Anna Natalizia Santoro; Carlo Dominici; Alessandro Fanzani; Luigi Pirtoli; Antonella Fioravanti; Vincenzo Tombolini; Sara Cheleschi; Paolo Tini
Journal:  J Cancer Res Clin Oncol       Date:  2019-01-30       Impact factor: 4.553

7.  Effects of resveratrol and methoxyamine on the radiosensitivity of iododeoxyuridine in U87MG glioblastoma cell line.

Authors:  Samideh Khoei; Mohsen Shoja; Ahmad Mostaar; Fariborz Faeghi
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-08

8.  Found in translation: Integrating laboratory and clinical oncology research.

Authors:  H Wagner
Journal:  Biomed Imaging Interv J       Date:  2008-07-01

9.  Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay--a comparative study.

Authors:  Karl Buch; Tanja Peters; Thomas Nawroth; Markus Sänger; Heinz Schmidberger; Peter Langguth
Journal:  Radiat Oncol       Date:  2012-01-03       Impact factor: 3.481

10.  Human embryonic stem cell responses to ionizing radiation exposures: current state of knowledge and future challenges.

Authors:  Mykyta V Sokolov; Ronald D Neumann
Journal:  Stem Cells Int       Date:  2012-08-16       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.